Dr. Xiaochun Li receives funding from FNIH for methodological research
Dr. Xiaochun Li received funding from the Foundation for the National Institutes of Health (FNIH) for methodological research and software development, as part of the Observational Medical Outcomes Partnership (OMOP) initiative. FNIH is a nonprofit organization aimed at facilitating public- private partnerships for biomedical research. OMOP is a two year program supported by FNIH designed to develop, implement, and test the performance of analysis methods in identifying drug outcomes across multiple observational data sources. Indiana University is one OMOP partner and Regenstrief Institute is a subcontractor of the operation. Xiaochun Li’s work involves development of analytical approaches and software for pharmaco- epidemiologic studies.